NeuBase Therapeutics Inc
(NASDAQ:NBSE)
$0.85
-0.0198[-2.28%]
Last update: 5:06AM (Delayed 15-Minutes)
Get Real Time Here
$0.85
0[0.00%]
Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-2.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2022-10-21OppenheimerHartaj SinghDowngradesOutperformPerform---
2022-10-18RBC CapitalLeonid TimashevDowngradesOutperformSector PerformLowers12.001.00
2022-10-17Chardan CapitalKeay NakaeDowngradesBuyNeutral---
2022-08-12Chardan CapitalKeay NakaeMaintainsBuyLowers9.007.00

Related Companies

TickerCompanyChg %Mkt Cap
NBSENeuBase Therapeutics-2.28%3.2M
PSTVPlus Therapeutics-5.22%3.7M
PBLAPanbela Therapeutics-1.53%3.8M
THARTharimmune-7.5%3.3M
DRMADermata Therapeutics0.94%3.4M
Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There is no dividend information for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-2.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2022-10-21OppenheimerHartaj SinghDowngradesOutperformPerform---
2022-10-18RBC CapitalLeonid TimashevDowngradesOutperformSector PerformLowers12.001.00
2022-10-17Chardan CapitalKeay NakaeDowngradesBuyNeutral---
2022-08-12Chardan CapitalKeay NakaeMaintainsBuyLowers9.007.00

Related Companies

TickerCompanyChg %Mkt Cap
NBSENeuBase Therapeutics-2.28%3.2M
PSTVPlus Therapeutics-5.22%3.7M
PBLAPanbela Therapeutics-1.53%3.8M
THARTharimmune-7.5%3.3M
DRMADermata Therapeutics0.94%3.4M
Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There is no dividend information for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-2.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2022-10-21OppenheimerHartaj SinghDowngradesOutperformPerform---
2022-10-18RBC CapitalLeonid TimashevDowngradesOutperformSector PerformLowers12.001.00
2022-10-17Chardan CapitalKeay NakaeDowngradesBuyNeutral---
2022-08-12Chardan CapitalKeay NakaeMaintainsBuyLowers9.007.00

Related Companies

TickerCompanyChg %Mkt Cap
NBSENeuBase Therapeutics-2.28%3.2M
PSTVPlus Therapeutics-5.22%3.7M
PBLAPanbela Therapeutics-1.53%3.8M
THARTharimmune-7.5%3.3M
DRMADermata Therapeutics0.94%3.4M
Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There is no dividend information for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-2.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2022-10-21OppenheimerHartaj SinghDowngradesOutperformPerform---
2022-10-18RBC CapitalLeonid TimashevDowngradesOutperformSector PerformLowers12.001.00
2022-10-17Chardan CapitalKeay NakaeDowngradesBuyNeutral---
2022-08-12Chardan CapitalKeay NakaeMaintainsBuyLowers9.007.00

Related Companies

TickerCompanyChg %Mkt Cap
NBSENeuBase Therapeutics-2.28%3.2M
PSTVPlus Therapeutics-5.22%3.7M
PBLAPanbela Therapeutics-1.53%3.8M
THARTharimmune-7.5%3.3M
DRMADermata Therapeutics0.94%3.4M
Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There is no dividend information for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-2.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2022-10-21OppenheimerHartaj SinghDowngradesOutperformPerform---
2022-10-18RBC CapitalLeonid TimashevDowngradesOutperformSector PerformLowers12.001.00
2022-10-17Chardan CapitalKeay NakaeDowngradesBuyNeutral---
2022-08-12Chardan CapitalKeay NakaeMaintainsBuyLowers9.007.00

Related Companies

TickerCompanyChg %Mkt Cap
NBSENeuBase Therapeutics-2.28%3.2M
PSTVPlus Therapeutics-5.22%3.7M
PBLAPanbela Therapeutics-1.53%3.8M
THARTharimmune-7.5%3.3M
DRMADermata Therapeutics0.94%3.4M
Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There is no dividend information for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-2.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2022-10-21OppenheimerHartaj SinghDowngradesOutperformPerform---
2022-10-18RBC CapitalLeonid TimashevDowngradesOutperformSector PerformLowers12.001.00
2022-10-17Chardan CapitalKeay NakaeDowngradesBuyNeutral---
2022-08-12Chardan CapitalKeay NakaeMaintainsBuyLowers9.007.00

Related Companies

TickerCompanyChg %Mkt Cap
NBSENeuBase Therapeutics-2.28%3.2M
PSTVPlus Therapeutics-5.22%3.7M
PBLAPanbela Therapeutics-1.53%3.8M
THARTharimmune-7.5%3.3M
DRMADermata Therapeutics0.94%3.4M
Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There is no dividend information for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-2.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2022-10-21OppenheimerHartaj SinghDowngradesOutperformPerform---
2022-10-18RBC CapitalLeonid TimashevDowngradesOutperformSector PerformLowers12.001.00
2022-10-17Chardan CapitalKeay NakaeDowngradesBuyNeutral---
2022-08-12Chardan CapitalKeay NakaeMaintainsBuyLowers9.007.00

Related Companies

TickerCompanyChg %Mkt Cap
NBSENeuBase Therapeutics-2.28%3.2M
PSTVPlus Therapeutics-5.22%3.7M
PBLAPanbela Therapeutics-1.53%3.8M
THARTharimmune-7.5%3.3M
DRMADermata Therapeutics0.94%3.4M
Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There is no dividend information for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-2.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2022-10-21OppenheimerHartaj SinghDowngradesOutperformPerform---
2022-10-18RBC CapitalLeonid TimashevDowngradesOutperformSector PerformLowers12.001.00
2022-10-17Chardan CapitalKeay NakaeDowngradesBuyNeutral---
2022-08-12Chardan CapitalKeay NakaeMaintainsBuyLowers9.007.00

Related Companies

TickerCompanyChg %Mkt Cap
NBSENeuBase Therapeutics-2.28%3.2M
PSTVPlus Therapeutics-5.22%3.7M
PBLAPanbela Therapeutics-1.53%3.8M
THARTharimmune-7.5%3.3M
DRMADermata Therapeutics0.94%3.4M
Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There is no dividend information for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary

NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.1.751K / 2.327MMkt Cap3.170M
Day Range- - -52 Wk Range0.605 - 8.700
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-2.040
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2022-10-21OppenheimerHartaj SinghDowngradesOutperformPerform---
2022-10-18RBC CapitalLeonid TimashevDowngradesOutperformSector PerformLowers12.001.00
2022-10-17Chardan CapitalKeay NakaeDowngradesBuyNeutral---
2022-08-12Chardan CapitalKeay NakaeMaintainsBuyLowers9.007.00

Related Companies

TickerCompanyChg %Mkt Cap
NBSENeuBase Therapeutics-2.28%3.2M
PSTVPlus Therapeutics-5.22%3.7M
PBLAPanbela Therapeutics-1.53%3.8M
THARTharimmune-7.5%3.3M
DRMADermata Therapeutics0.94%3.4M
Q

How do I buy NeuBase Therapeutics (NBSE) stock?

A

You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuBase Therapeutics's (NBSE) competitors?

Q

What is the target price for NeuBase Therapeutics (NBSE) stock?

A

The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuBase Therapeutics (NBSE)?

A

The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.

Q

Does NeuBase Therapeutics (NBSE) pay a dividend?

A

There is no dividend information for NeuBase Therapeutics.

Q

When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?

A

NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.

Q

Is NeuBase Therapeutics (NBSE) going to split?

A

There is no upcoming split for NeuBase Therapeutics.

Q

What sector and industry does NeuBase Therapeutics (NBSE) operate in?

A

NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.